ATE460493T1 - Gesteigerte genexpression - Google Patents
Gesteigerte genexpressionInfo
- Publication number
- ATE460493T1 ATE460493T1 AT02708511T AT02708511T ATE460493T1 AT E460493 T1 ATE460493 T1 AT E460493T1 AT 02708511 T AT02708511 T AT 02708511T AT 02708511 T AT02708511 T AT 02708511T AT E460493 T1 ATE460493 T1 AT E460493T1
- Authority
- AT
- Austria
- Prior art keywords
- gene expression
- polynucleotides
- nucleic acid
- increased gene
- flanked
- Prior art date
Links
- 230000014509 gene expression Effects 0.000 title abstract 2
- 108091029523 CpG island Proteins 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 108091033319 polynucleotide Proteins 0.000 abstract 2
- 102000040430 polynucleotide Human genes 0.000 abstract 2
- 239000002157 polynucleotide Substances 0.000 abstract 2
- 239000013598 vector Substances 0.000 abstract 2
- 230000003115 biocidal effect Effects 0.000 abstract 1
- 239000003550 marker Substances 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/46—Vector systems having a special element relevant for transcription elements influencing chromatin structure, e.g. scaffold/matrix attachment region, methylation free island
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Communicable Diseases (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28160501P | 2001-04-05 | 2001-04-05 | |
| GB0108605A GB0108605D0 (en) | 2001-04-05 | 2001-04-05 | Improved gene expression |
| GB0109335A GB0109335D0 (en) | 2001-04-17 | 2001-04-17 | Improved gene expression |
| US29867501P | 2001-06-15 | 2001-06-15 | |
| PCT/GB2002/001479 WO2002081677A2 (en) | 2001-04-05 | 2002-04-05 | Improved gene expression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE460493T1 true ATE460493T1 (de) | 2010-03-15 |
Family
ID=27447937
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02708511T ATE460493T1 (de) | 2001-04-05 | 2002-04-05 | Gesteigerte genexpression |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP2224010B1 (enExample) |
| JP (5) | JP2005500019A (enExample) |
| CN (1) | CN1500147B (enExample) |
| AT (1) | ATE460493T1 (enExample) |
| AU (1) | AU2002242872B2 (enExample) |
| CA (1) | CA2443275C (enExample) |
| DE (1) | DE60235616D1 (enExample) |
| ES (1) | ES2339428T3 (enExample) |
| WO (1) | WO2002081677A2 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7812148B2 (en) | 2001-04-05 | 2010-10-12 | Millipore Corporation | Vectors comprising CpG islands without position effect varigation and having increased expression |
| JP4709743B2 (ja) * | 2003-02-01 | 2011-06-22 | ミリポア・コーポレイション | 改善された発現エレメント |
| DK1776460T3 (da) | 2004-08-03 | 2010-04-12 | Geneart Ag | Fremgangsmåde til modulering af genekspression ved ændring af CpG-indholdet |
| GB0504587D0 (en) | 2005-03-05 | 2005-04-13 | Ml Lab Plc | Vectors comprising guinea pig CMV regulatory elements |
| ES2330784T3 (es) * | 2005-03-05 | 2009-12-15 | Millipore Corporation | Vectores que comprenden nuevos elementos reguladores. |
| GB0509965D0 (en) * | 2005-05-17 | 2005-06-22 | Ml Lab Plc | Improved expression elements |
| US20080124760A1 (en) | 2006-07-26 | 2008-05-29 | Barbara Enenkel | Regulatory Nucleic Acid Elements |
| CN104531699B (zh) * | 2014-10-09 | 2017-03-15 | 河南农业大学 | 一种增强外源基因表达的猪的ucoe调控元件片段 |
| WO2018175153A1 (en) * | 2017-03-19 | 2018-09-27 | Applied Stemcell, Inc. | Novel integration sites and uses thereof |
| EP3805396B1 (en) * | 2018-05-24 | 2024-09-11 | National University Corporation Hokkaido University | Novel vector and use thereof |
| CN116790606B (zh) * | 2023-08-23 | 2023-11-07 | 威瑞生物科技(昆明)有限责任公司 | 一种遍在染色质开放表达元件、重组表达载体及其制备方法与应用 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0918874T3 (da) | 1996-08-16 | 2001-05-14 | Medical Res Council | Selvreplikerende episomale ekspressionsvektorer, som giver vævsspecifik genekspression |
| WO2000005393A2 (en) * | 1998-07-21 | 2000-02-03 | Cobra Therapeutics Limited | A polynucleotide comprising a ubiquitous chromatin opening element (ucoe) |
| KR100996016B1 (ko) * | 2000-09-20 | 2010-11-22 | 밀리포어 코포레이션 | 폴리뉴클레오티드 |
-
2002
- 2002-04-05 ES ES02708511T patent/ES2339428T3/es not_active Expired - Lifetime
- 2002-04-05 AU AU2002242872A patent/AU2002242872B2/en not_active Ceased
- 2002-04-05 CN CN028077113A patent/CN1500147B/zh not_active Expired - Fee Related
- 2002-04-05 JP JP2002580040A patent/JP2005500019A/ja active Pending
- 2002-04-05 WO PCT/GB2002/001479 patent/WO2002081677A2/en not_active Ceased
- 2002-04-05 AT AT02708511T patent/ATE460493T1/de not_active IP Right Cessation
- 2002-04-05 CA CA2443275A patent/CA2443275C/en not_active Expired - Fee Related
- 2002-04-05 EP EP10155532A patent/EP2224010B1/en not_active Expired - Lifetime
- 2002-04-05 EP EP02708511A patent/EP1373535B1/en not_active Expired - Lifetime
- 2002-04-05 DE DE60235616T patent/DE60235616D1/de not_active Expired - Lifetime
-
2008
- 2008-09-22 JP JP2008243399A patent/JP2009017886A/ja active Pending
-
2009
- 2009-11-24 JP JP2009266880A patent/JP2010042033A/ja active Pending
-
2010
- 2010-06-29 JP JP2010148212A patent/JP2010259439A/ja active Pending
-
2011
- 2011-06-27 JP JP2011142362A patent/JP2011193881A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2002242872B2 (en) | 2006-12-14 |
| JP2010259439A (ja) | 2010-11-18 |
| JP2005500019A (ja) | 2005-01-06 |
| JP2011193881A (ja) | 2011-10-06 |
| CA2443275A1 (en) | 2002-10-17 |
| AU2002242872A2 (en) | 2002-10-21 |
| WO2002081677A2 (en) | 2002-10-17 |
| CN1500147B (zh) | 2011-05-04 |
| DE60235616D1 (de) | 2010-04-22 |
| JP2010042033A (ja) | 2010-02-25 |
| WO2002081677A3 (en) | 2002-12-19 |
| JP2009017886A (ja) | 2009-01-29 |
| CN1500147A (zh) | 2004-05-26 |
| EP2224010B1 (en) | 2012-06-20 |
| EP1373535B1 (en) | 2010-03-10 |
| EP2224010A1 (en) | 2010-09-01 |
| EP1373535A2 (en) | 2004-01-02 |
| CA2443275C (en) | 2013-02-05 |
| ES2339428T3 (es) | 2010-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE460493T1 (de) | Gesteigerte genexpression | |
| DE69937732D1 (de) | Biosynthetische gene zur spinosyn-insektizidherstellung | |
| DE69535563D1 (de) | Transgene pflanzen, die dna-konstrukteexpremieren, die mehrere virusresistenz-verleihende gene enthalten | |
| DK2295441T3 (da) | Bicyklonukleosidoligonukleotidanalog | |
| WO2003008576A3 (de) | Synthetische doppelsträngige oligonucleotide zur gezielten hemmung der genexpression | |
| WO2003084477A3 (en) | Mammalian cdr mimetibodies, compositions, methods and uses | |
| DK0910633T3 (da) | Hybrid polyketidsyntase I-gen | |
| EP1578901A4 (en) | LINEAR DNA FRAGMENTS FOR GENE EXPRESSION | |
| EP1430126A4 (en) | DNA SEQUENCES FOR THE HUMAN GENES OF ANGIOGENESIS | |
| EP1142591A4 (en) | gene carriers | |
| ATE384118T1 (de) | Gene von felincalizivirus und impstoffe, die diese gene enthalten | |
| WO2002022835A3 (en) | Targeted genetic manipulation using mu bacteriophage cleaved donor complex | |
| TR199802648A3 (tr) | Gen tedavisi için nüklein asit yapilari. | |
| AU6879994A (en) | Nucleic acid markers for rice blast resistance genes and rice blast resistance genes isolated by the use of these markers | |
| EP1082437A4 (en) | XENOBIOTIC INDUCTION OF GENE EXPRESSION | |
| DE69736002D1 (de) | GEN ASSOZIIERT MIT IgA GLOMERULONEPHRITIS | |
| FR2771753B1 (fr) | Gene de chitine-desacetylase, sequence d'adn hybridable, vecteur plasmidique qui le contient et organisme transforme par ce vecteur plasmidique | |
| WO2002010364A3 (en) | Methods for enhancing targeted gene alteration using oligonucleotides | |
| GB0122828D0 (en) | Gene expression construct | |
| AU6879894A (en) | Nucleic acid markers for rice blast resistance genes and rice blast resistance genes isolated by the use of these markers | |
| EP1317560A4 (en) | DNA VECTORS WHICH COULD REENGANIZE | |
| AU2002326361A1 (en) | Nucleic acid detection assay control genes | |
| DE60328814D1 (de) | Hm1.24 verwertende krebsvakzine | |
| IE892131L (en) | Marker genes for genetic manipulation | |
| IT1320168B1 (it) | Oligonucleotidi sintetici in grado di indurre il differenziamentoeritroide. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |